Research output per year
Research output per year
Fingerprint
Dive into the research topics where Simon Peter Gampenrieder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Rinnerthaler, G. (First author), Egle, D., Bartsch, R., Schmitt, C. A., Petzer, A., Balic, M., Petru, E., Denison, U., Singer, C. F., Bjelic-Radisic, V., Gampenrieder, S. P. (Co-author), Knauer, M., Sotlar, K. (Co-author), Brunner, C. (Co-author), Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z., Filipits, M. & Gili, M. & 10 others, , 16 Jan 2025, In: NATURE CANCER. 13 p.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Antibody-drug conjugates (ADC special)-part 2: New therapy options in lung and breast cancer
Gampenrieder, S. (First author), Sept 2024, In: memo - Magazine of European Medical Oncology. 17, 3, p. 156-157 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Klocker, E. V., Hasenleithner, S., Bartsch, R., Gampenrieder, S. P. (Co-author), Egle, D., Singer, C. F., Rinnerthaler, G. (Co-author), Hubalek, M., Schmitz, K., Bago-Horvath, Z., Petzer, A., Heibl, S., Heitzer, E., Balic, M. & Gnant, M., 12 Jun 2024, In: MOLECULAR ONCOLOGY. 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Web of Science) -
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Wimmer, K., Hlauschek, D., Balic, M., Pfeiler, G., Greil, R., Singer, C. F., Halper, S., Steger, G., Suppan, C., Gampenrieder, S. P., Helfgott, R., Egle, D., Filipits, M., Jakesz, R., Sölkner, L., Fesl, C., Gnant, M. & Fitzal, F., 5 May 2024, (E-pub ahead of print) In: BREAST CANCER RESEARCH AND TREATMENT .Research output: Contribution to journal › Correction › peer-review
1 Citation (Web of Science) -
Electrotherapy as treatment for chemotherapy-induced peripheral neuropathy — a randomized controlled trial
Sassmann, R. (First author), Gampenrieder, S. P. (First author), Rieder, F. (Co-author), Johansson, T. (Co-author), Rinnerthaler, G. (Co-author), Castagnaviz, V., Lampl, K. (Co-author), Herfert, J. (Co-author), Kienberger, Y. T. (Co-author), Flamm, M. (Co-author), Schaffler-Schaden, D. (Last author) & Greil, R. (Last author), 24 Dec 2024, In: Frontiers in Neurology.Research output: Contribution to journal › Original Article › peer-review
Open Access1 Citation (Web of Science)
Projects
- 2 Finished
-
The effect of high tone therapy in chemotherapy-induced peripheral neuropathy (HIT-CIPN)
Schaffler-Schaden, D. (Further contributor), Johansson, T. (CoPI), Gampenrieder, S. P. (CoPI), Rinnerthaler, G. (Further contributor), Lampl, K. (Further contributor), Greil, R. (Further contributor), Flamm, M. (Further contributor), Dengg, N. (Further contributor), Sassmann, R. (PI), Herfert, J. (Further contributor), Niebauer, J. (Further contributor), Rieder, F. (Further contributor) & Kienberger, Y. (Further contributor)
1/01/19 → 1/01/21
Project: Research
-
Analysis of circulating cell-free DNA to monitor tumor burden and treatment in head and neck cancer
Gampenrieder, S. P. (Further contributor), Hufnagl, C. (PI), Melchardt, T. (Further contributor), Magnes, T. (Further contributor), Rinnerthaler, G. (Further contributor), Egle, A. (Further contributor), Leisch, M. (Further contributor), Weiss, L. (Further contributor) & Greil, R. (Further contributor)
1/04/17 → 1/04/18
Project: Research
-
CDK4/6: Intranukleäre vs. zytoplasmische Inhibition
Gampenrieder, S. P. (Invited speaker)
2016Activity: Talk or presentation › Oral presentation
-
Tumor-infiltrierende Lymphozyten, Immuntherapie und Gensignaturen
Gampenrieder, S. P. (Invited speaker)
2016Activity: Talk or presentation › Oral presentation
-
Update HER2-Therapie: Ist weniger mehr? Ist es bereits Zeit für Deeskalation?
Gampenrieder, S. P. (Invited speaker)
2015Activity: Talk or presentation › Oral presentation
-
Neue Therapieansätze beim fortgeschrittenen Mammakarzinom: Fokus auf den CDK4/6 Pathway
Gampenrieder, S. P. (Invited speaker)
2015Activity: Talk or presentation › Oral presentation
-
Was kann die Immuntherapie?
Gampenrieder, S. P. (Invited speaker)
2015Activity: Talk or presentation › Oral presentation